Nanobiotix

Three blocks displaying from left to right a person a handshake and another person

Nanobiotix tweaks J&J deal for cancer drug to conserve cash

Nanobiotix has tweaked the terms of a deal with J&J over the French biotech’s phase 3-stage cancer drug to keep the cash flowing through to next year.

James Waldron Mar 18, 2025 5:23am

Illumina nets new CEO—Chutes & Ladders

Sep 8, 2023 9:30am

J&J seizes on cash crunch to bag late-phase cancer candidate

Jul 10, 2023 5:30am

Nanobiotix scales down to close gap between cash runway and data

May 19, 2022 5:51am